Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome

Journal of Medical Microbiology

Volumn 60, Issue 2, 2011, Pages 236-245

  Kerckhoffs, Angèle P M ^a   Ben Amor, Kaouther ^b   Samsom, Melvin ^a   Van Der Rest, Michel E ^c   De Vogel, Joris ^c   Knol, Jan ^b   Akkermans, Louis M A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

^c BioVisible BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ADULT; ARTICLE; BACTERIAL GENE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLONING; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DUODENUM; DUODENUM MUCOSA; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE BRUSH BORDER; INTESTINE FLORA; IRRITABLE COLON; MALE; MOLECULAR BIOLOGY; PARASITE PREVALENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA FINGERPRINTING;

ADULT; DUODENUM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FECES; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MOLECULAR TYPING; NUCLEIC ACID DENATURATION; POLYMERASE CHAIN REACTION; PREVALENCE; PSEUDOMONAS AERUGINOSA; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S;

EID: 79251495453     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.022848-0     Document Type: Article

References (63)

1. Adlard, P. A., Kirov, S. M., Sanderson, K. & Cox, G. E. (1998). Pseudomonas aeruginosa as a cause of infectious diarrhoea. Epidemiol Infect 121, 237-241.
2. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. (1990). Basic local alignment search tool. J Mol Biol 215, 403-410.
3. Balsari, A., Ceccarelli, A., Dubini, F., Fesce, E. & Poli, G. (1982). The fecal microbial population in the irritable bowel syndrome. Microbiologica 5, 185-194.
4. Baron, A. D. & Hollander, H. (1993). Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Respir Dis 148, 992-996.
5. Bleday, R., Braidt, J., Ruoff, K., Shellito, P. C. & Ackroyd, F. W. (1993). Quantitative cultures of the mucosal-associated bacteria in the mechanically prepared colon and rectum. Dis Colon Rectum 36, 844-849.
6. Bonten, M. J., Bergmans, D. C., Speijer, H. & Stobberingh, E. E. (1999). Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control. Am J Respir Crit Care Med 160, 1212-1219.
7. Brooks, S. P., McAllister, M., Sandoz, M. & Kalmokoff, M. L. (2003). Culture-independent phylogenetic analysis of the faecal flora of the rat. Can J Microbiol 49, 589-601.
8. Collins, S. M., Piche, T. & Rampal, P. (2001). The putative role of inflammation in the irritable bowel syndrome. Gut 49, 743-745.
9. Dulon, S., Leduc, D., Cottrell, G. S., D'Alayer, J., Hansen, K. K., Bunnett, N. W., Hollenberg, M. D., Pidard, D. & Chignard, M. (2005). Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am J Respir Cell Mol Biol 32, 411-419.
10. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E. & Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
11. Edlund, C. & Nord, C. E. (2000). Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J Antimicrob Chemother 46 (Suppl. 1), 41-48.
12. Fichtenbaum, C. J., Woeltje, K. F. & Powderly, W. G. (1994). Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 19, 417-422.
13. Flanagan, J. L.,Brodie, E. L.,Weng, L., Lynch,S.V.,Garcia,O., Brown, R., Hugenholtz, P., DeSantis, T. Z., Andersen, G. L. & other authors (2007). Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 45, 1954-1962.
14. Furrie, E. (2006). A molecular revolution in the study of intestinal microflora. Gut 55, 141-143.
15. George, S. E., Walsh, D. B., Stead, A. G. & Claxton, L. D. (1989). Effect of ampicillin-induced alterations in murine intestinal microbiota on the survival and competition of environmentally released pseudomonads. Fundam Appl Toxicol 13, 670-680.
16. Gorbach, S. L., Barza, M., Giuliano, M. & Jacobus, N. V. (1988). Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers. Eur J Clin Microbiol Infect Dis 7, 98-102.
17. Hentges, D. J., Stein, A. J., Casey, S. W. & Que, J. U. (1985). Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance. Infect Immun 47, 118-122.
18. Hooper, L. V. & Gordon, J. I. (2001). Commensal host-bacterial relationships in the gut. Science 292, 1115-1118.
19. Hopkins, M. J. & Macfarlane, G. T. (2002). Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51, 448-454.
20. Kassinen, A., Krogius-Kurikka, L., Makivuokko, H., Rinttila, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J. & Palva, A. (2007). The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133, 24-33.
21. Kerckhoffs, A. P. M., Samsom, M., van der Rest, M. E., de Vogel, J., Knol, J., Ben-Amor, K. & Akkermans, L. M. A. (2009). Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients assessed by molecular analysis. World J Gastroenterol 15, 2887-2892.
22. Kessner, D. M. & Lepper, M. H. (1967). Epidemiologic studies on gram-negative bacilli in the hospital and community. Am J Epidemiol 85, 45-60.
23. King, T. S., Elia, M. & Hunter, J. O. (1998). Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352, 1187-1189.
24. Kühbacher, T., Ott, S. J., Helwig, U., Mimura, T., Rizzello, F., Kleessen, B., Gionchetti, P., Blaut, M., Campieri, M. & other authors (2006). Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut 55, 833-841.
25. León-Barúa, R., Gilman, R. H., Rodríguez, C., Bonilla, J. J., Yi, A., Maúrtua, D. & Sack, R. B. (1993). Comparison of three methods to obtain upper small bowel contents for culture. Am J Gastroenterol 88, 925-928.
26. Lepage, P., Seksik, P., Sutren, M., de la Cochetiere, M. F., Jian, R., Marteau, P. & Dore, J. (2005). Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 11, 473-480.
27. Levison, M. E. (1973). Effect of colon flora and short-chain fatty acids on growth in vitro of Pseudomonas aeruginosa and Enterobacteriaceae. Infect Immun 8, 30-35.
28. Levy, J. (2000). The effects of antibiotic use on gastrointestinal function. Am J Gastroenterol 95, S8-S10.
29. Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., Zhang, Y., Shen, J., Pang, X. & other authors (2008). Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 105, 2117-2122.
30. Liu, W. & Saint, D. A. (2002a). A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 302, 52-59.
31. Liu, W. & Saint, D. A. (2002b). Validation of a quantitative method for real time PCR kinetics. Biochem Biophys Res Commun 294, 347-353.
32. Livermore, D. M. (1992). Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 36, 2046-2048.
33. Madden, J. A. & Hunter, J. O. (2002). A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 88, S67-S72.
34. Mah, T. F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S. & O'Toole, G. A. (2003). A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426, 306-310.
35. Mai, V. & Morris, J. G., Jr (2004). Colonic bacterial flora: changing understandings in the molecular age. J Nutr 134, 459-464.
36. Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R. & Palva, A. (2005). Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100, 373-382.
37. Masuda, N., Gotoh, N., Ishii, C., Sakagawa, E., Ohya, S. & Nishino, T. (1999). Interplay between chromosomal β-lactamase and the MexAB-OprM efflux system in intrinsic resistance to β-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother 43, 400-402.
38. Maxwell, P. R., Rink, E., Kumar, D. & Mendall, M. A. (2002). Antibiotics increase functional abdominal symptoms. Am J Gastroenterol 97, 104-108.
39. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., Cresci, A., Silvi, S., Orpianesi, C. & other authors (2006). Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72, 1027-1033.
40. Muyzer, G. & Smalla, K. (1998). Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie van Leeuwenhoek 73, 127-141.
41. Muyzer, G., de Waal, E. C. & Uitterlinden, A. G. (1993). Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl Environ Microbiol 59, 695-700.
42. Nadkarni, M. A., Martin, F. E., Jacques, N. A. & Hunter, N. (2002). Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148, 257-266.
43. Niedzielin, K., Kordecki, H. & Birkenfeld, B. (2001). A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13, 1143-1147.
44. Nobaek, S., Johansson, M. L., Molin, G., Ahrne, S. & Jeppsson, B. (2000). Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95, 1231-1238.
45. Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. (2000). High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-1254.
46. O'Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O'Sullivan, G. C., Kiely, B., Collins, J. K. & other authors (2005). Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128, 541-551.
47. Parry, S. D., Stansfield, R., Jelley, D., Gregory, W., Phillips, E., Barton, J. R. & Welfare, M. R. (2003). Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 98, 1970-1975.
48. Pimentel, M., Chow, E. J. & Lin, H. C. (2000). Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 95, 3503-3506.
49. Pirnay, J. P., De Vos, D., Duinslaeger, L., Reper, P., Vandenvelde, C., Cornelis, P. & Vanderkelen, A. (2000). Quantitation of Pseudomonas aeruginosa in wound biopsy samples: from bacterial culture to rapid 'real-time' polymerase chain reaction. Crit Care 4, 255-261.
50. Posserud, I., Stotzer, P. O., Bjornsson, E. S., Abrahamsson, H. & Simrén, M. (2007). Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 56, 802-808.
51. Quigley, E. M. (2007). Probiotics in irritable bowel syndrome: an immunomodulatory strategy? J Am Coll Nutr 26, 684S-690S.
52. Rodríguez, L. A. & Ruiǵmez, A. (1999). Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 318, 565-566.
53. Sanguinetti, C. J., Dias, N. E. & Simpson, A. J. (1994). Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17, 914-921.
54. Si, J. M., Yu, Y. C., Fan, Y. J. & Chen, S. J. (2004). Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 10, 1802-1805.
55. Speert, D. P., Campbell, M. E., Davidson, A. G. & Wong, L. T. (1993). Pseudomonas aeruginosa colonization of the gastrointestinal tract in patients with cystic fibrosis. J Infect Dis 167, 226-229.
56. Spiller, R. C. (2007). Role of infection in irritable bowel syndrome. J Gastroenterol 42 (Suppl. 17), 41-47.
57. Suau, A., Bonnet, R., Sutren, M., Godon, J. J., Gibson, G. R., Collins, M. D. & Dore, J. (1999). Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65, 4799-4807.
58. Vaughan, E. E., Schut, F., Heilig, H. G., Zoetendal, E. G., de Vos, W. M. & Akkermans, A. D. (2000). A molecular view of the intestinal ecosystem. Curr Issues Intest Microbiol 1, 1-12.
59. Vergnolle, N. (2005). Clinical relevance of proteinase activated receptors (pars) in the gut. Gut 54, 867-874.
60. Walters, M. C., III, Roe, F., Bugnicourt, A., Franklin, M. J. & Stewart, P. S. (2003). Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47, 317-323.
61. Woodmansey, E. J., McMurdo, M. E., Macfarlane, G. T. &Macfarlane, S. (2004). Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70, 6113-6122.
62. Zhang, Z., Schwartz, S., Wagner, L. & Miller, W. (2000). A greedy algorithm for aligning DNA sequences. J Comput Biol 7, 203-214.
63. Zoetendal, E. G., von Wright, A., Vilpponen-Salmela, T., Ben Amor, K., Akkermans, A. D. & de Vos, W. M. (2002). Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68, 3401-3407.